Three kidney care providers –– Fresenius Health Partners, Cricket Health and InterWell Health –– have entered into a binding agreement to merge.

The merger, valued at a whopping $2.4 billion, combines three value-based care companies. Fresenius Health is the value-based care division of Fresenius Medical Care North America. InterWell Health is the leading physician organization driving innovation in the kidney care space in the U.S.  Cricket Health is a U.S. provider of value-based kidney care with a leading patient engagement and data platform.

Each company brings unique synergies to the deal. Fresenius has expertise in kidney care value-based contracting and performance, while InterWell Health boasts clinical care models and a strong network of 1,600 nephrologists. Cricket Health offers its proprietary informatics, StageSmart and patient engagement platforms for its tech-enabled care model.

The merger is part of Fresenius' transformation program FME25, designed to change its operating model to provide the base for future sustainable growth. 

“This effort is an important next step in executing Fresenius Medical Care’s growth strategy 2025 to further expand along the renal care continuum and to refine and grow our future operating model in care delivery in the U.S. as part of the FME25 transformation,” Rice Powell, CEO of Fresenius Medical Care. “In bringing together the expertise and competence of three leading partners we will be broadening our offer and adding significant value to patients with chronic kidney disease all over the U.S.”